7 January 2021
Latham & Watkins advises the underwriters in Harpoon Therapeutics Public Offering
Advising firms
Deal team
15 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Brian Cuneo Lead | Latham & Watkins LLP | Partner | life sciences capital markets | Bay Area |
| John Williams Lead | Latham & Watkins LLP | Partner | life sciences capital markets | Bay Area |
| Michelle Lu | Latham & Watkins LLP | Associate | life sciences capital markets | Not stated |
| Taimi Jacobson | Latham & Watkins LLP | Associate | life sciences capital markets | Not stated |
| Melinda Vanderburg | Latham & Watkins LLP | Associate | life sciences capital markets | Not stated |
| Elizabeth Richards | Latham & Watkins LLP | Partner | FDA regulatory matters | Washington, DC |
| Barrett Tenbarge | Latham & Watkins LLP | Associate | FDA regulatory matters | Not stated |
| Lacey Henry | Latham & Watkins LLP | Associate | FDA regulatory matters | Not stated |
| Betty Pang | Latham & Watkins LLP | Counsel | healthcare regulatory matters | Bay Area |
| Grace Lee | Latham & Watkins LLP | Partner | tax matters | Bay Area |
| Gregory Conyers | Latham & Watkins LLP | Associate | tax matters | Not stated |
| Chris Hazuka | Latham & Watkins LLP | Partner | technology transactions matters | Bay Area |
| Peggy Ni | Latham & Watkins LLP | Associate | technology transactions matters | Not stated |
| Jay Metz | Latham & Watkins LLP | Partner | benefits and compensation matters | Bay Area |
| Brianna Stellpflug | Latham & Watkins LLP | Associate | benefits and compensation matters | Not stated |
12 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 100m ($100.0 million)
- What the figure measures
- Issue size
- Client
- Not stated
- Counterparties
- Harpoon Therapeutics, Inc. (Issuer)